ARTICANZ - Beta (ver 0.91)
Annotated Registry of Trials in Cancer, Australia and New Zealand Ed.
- Results - location/NSW/2560-Campbelltown-GenesisCare-Campbelltown
Home
By cancer type
By drug class
By site
Data
FAQ
About
⚠
ARTICANZ provides informational content about cancer drug trials in Australia/NZ that is updated weekly but may not be completely accurate, and should not replace medical advice from qualified healthcare professionals. The platform is intended to be useful, providing information "as is" without warranties. Non-medical users must always consult healthcare providers for all clinical decisions.
Search results
6
trial(s) found.
NCT07218380
Advanced
Phase 3
Recruiting
FORAGER-2
: A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Vepugratinib Combined With Enfortumab Vedotin and Pembrolizumab in Adults With Untreated Locally Advanced or Metastatic Urothelial Carcinoma With an FGFR3 Genetic Alteration
anti-NECTIN4 antibody-drug conjugate
placebo
Urothelial carcinoma
NSW
2031 - Randwick - Prince of Wales Hospital
2109 - North Ryde - Macquarie University Hospital
2298 - Waratah - Calvary Mater Newcastle Medical Oncology
2560 - Campbelltown - GenesisCare Campbelltown
VIC
3021 - St Albans - Western Health - Sunshine Hospital
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
3128 - Box Hill - Box Hill Hospital - Eastern Health
QLD
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre
WA
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre
NCT07190248
Advanced
Phase 3
Recruiting
A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084 in Combination With Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus MK-3475A in Combination With Pemetrexed/Platinum (Carboplatin or Cisplatin) Chemotherapy as First-line Treatment of Participants With KRAS G12C-Mutant, Advanced or Metastatic Nonsquamous NSCLC (KANDLELIT-007) (
1084-007
)
KRAS G12C inhibitor
antimetabolite
platinum-based antineoplastic agent
Non-small cell lung cancer
NSW
2086 - Frenchs Forest - Northern Beaches Hospital
2560 - Campbelltown - GenesisCare Campbelltown
QLD
4032 - Chermside - The Prince Charles Hospital
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre
NCT06855771
Advanced
Phase 2
Recruiting
A Multicenter, Randomized, Open-label, Phase 2 Study Evaluating the Safety and Efficacy of Navlimetostat (BMS-986504) Monotherapy in Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion After Progression on Prior Therapies (
CA240-0009
)
PRMT5 inhibitor,MTA-co-operative
Non-small cell lung cancer
NSW
2050 - Camperdown - Chris O'Brien Lifehouse
2560 - Campbelltown - GenesisCare Campbelltown
QLD
4102 - Woolloongabba - Princess Alexandra Hospital
SA
5000 - South Australia - GenesisCare St Andrews Hospital
NCT06764485
Advanced
Phase 3
Recruiting
A Phase 3, Two-part, Randomized, Open-label, Adaptive Study Comparing BMS-986365 Versus Investigator's Choice of Therapy Comprising Either Docetaxel or Second Androgen Receptor Pathway Inhibitor (ARPI), in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) -
rechARge
taxane
Castrate-resistant prostate cancer
NSW
2010 - Darlinghurst - St Vincent's Hospital Sydney - The Kinghorn Cancer Centre
2076 - Wahroonga - Sydney Adventist Hospital
2109 - North Ryde - Macquarie University Hospital
2444 - Port Macquarie - Mid North Coast Cancer Institute-Port Macquarie Base Hospital
2560 - Campbelltown - GenesisCare Campbelltown
VIC
3000 - Melbourne - Peter MacCallum Cancer Centre
3004 - Melbourne, Southbank - Alfred Health
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
3144 - Malvern - Cabrini Health, Cabrini Cancer Care Centre
QLD
4120 - Greenslopes - Greenslopes Private Hospital
4215 - Southport - Tasman Oncology
SA
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre
5037 - Kurralta Park - Icon Cancer Centre Adelaide
5112 - Elizabeth Vale - Lyell McEwin Hospital
WA
6150 - Murdoch - Fiona Stanley Hospital
TAS
7000 - Hobart - ICON Cancer Care Hobart
NCT06532006
Advanced
Phase 3
Recruiting
A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) in Combination With Trastuzumab and Chemotherapy (XELOX) Versus Trastuzumab and Chemotherapy (XELOX) With or Without Pembrolizumab for the First Line Treatment of Locally Advanced or Metastatic Gastroesophageal Junction and Gastric Cancer (
HLX22-GC-301
)
anti-PD-1 monoclonal antibody
Gastric cancer
Gastroesophageal junction adenocarcinoma
HER2-positive gastric cancer
NSW
2109 - North Ryde - Macquarie University Hospital
2139 - Concord - Concord Repatriation General Hospital
2250 - Gosford - Central Coast Cancer Centre, Gosford Hospital
2560 - Campbelltown - GenesisCare Campbelltown
VIC
3065 - Fitzroy - St Vincent's Hospital Melbourne
3199 - Frankston - Peninsula Health Frankston Hospital
QLD
4556 - Buderim - Sunshine Coast Haematology and Oncology Clinic
NCT04889924
Radonc
NA
Recruiting
Axillary Lymph Node Dissection Versus Axillary Radiotherapy in Breast Cancer Patients With Positive Sentinel Node After Neoadjuvant Therapy: A Multicenter Randomized Study (
ADARNAT
)
radiotherapy
Breast cancer
NSW
2060 - Sydney - GenesisCare Mater
2065 - St Leonards - GenesisCare North Shore Private Hospital
2086 - Frenchs Forest - GenesisCare Frenchs Forest
2153 - Bella Vista - GenesisCare Norwest
2220 - Hurstville - GenesisCare Hurstville
2560 - Campbelltown - GenesisCare Campbelltown
Additional search terms:
API and Webpage URLs:
Copy /Bookmark
Filters
Recruitment Status
Recruiting (6)
Recruitment Country and State
NSW (6)
QLD (5)
VIC (3)
WA (2)
SA (2)
TAS (1)
Phase
Phase 2 (1)
Phase 3 (4)
Trial Type
Advanced (5)
Radonc (1)
Cancer Therapy Class
PD-1
50%
PD-1/PD-L1
50%
FGFR
17%
FGFR3
17%
Nectin4
17%
KRAS
17%
KRAS G12C
17%
PRMT5
17%
AR
17%
CYP17A1
17%
AR
17%
androgen axis
17%
ERBB2
17%
Facility
2560 - Campbelltown - GenesisCare Campbelltown (6)
2109 - North Ryde - Macquarie University Hospital (3)
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre (2)
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre (2)
2031 - Randwick - Prince of Wales Hospital (1)
2298 - Waratah - Calvary Mater Newcastle Medical Oncology (1)
3021 - St Albans - Western Health - Sunshine Hospital (1)
3128 - Box Hill - Box Hill Hospital - Eastern Health (1)
6009 - Nedlands - Sir Charles Gairdner Hospital - WA Cancer Centre (1)
2086 - Frenchs Forest - Northern Beaches Hospital (1)
4032 - Chermside - The Prince Charles Hospital (1)
2050 - Camperdown - Chris O'Brien Lifehouse (1)
4102 - Woolloongabba - Princess Alexandra Hospital (1)
5000 - South Australia - GenesisCare St Andrews Hospital (1)
2010 - Darlinghurst - St Vincent's Hospital Sydney - The Kinghorn Cancer Centre (1)
2076 - Wahroonga - Sydney Adventist Hospital (1)
2444 - Port Macquarie - Mid North Coast Cancer Institute-Port Macquarie Base Hospital (1)
3000 - Melbourne - Peter MacCallum Cancer Centre (1)
3004 - Melbourne, Southbank - Alfred Health (1)
3144 - Malvern - Cabrini Health, Cabrini Cancer Care Centre (1)
4120 - Greenslopes - Greenslopes Private Hospital (1)
4215 - Southport - Tasman Oncology (1)
5000 - Adelaide - Royal Adelaide Hospital - Adelaide Cancer Centre (1)
5037 - Kurralta Park - Icon Cancer Centre Adelaide (1)
5112 - Elizabeth Vale - Lyell McEwin Hospital (1)
6150 - Murdoch - Fiona Stanley Hospital (1)
7000 - Hobart - ICON Cancer Care Hobart (1)
2139 - Concord - Concord Repatriation General Hospital (1)
2250 - Gosford - Central Coast Cancer Centre, Gosford Hospital (1)
3065 - Fitzroy - St Vincent's Hospital Melbourne (1)
3199 - Frankston - Peninsula Health Frankston Hospital (1)
4556 - Buderim - Sunshine Coast Haematology and Oncology Clinic (1)
2060 - Sydney - GenesisCare Mater (1)
2065 - St Leonards - GenesisCare North Shore Private Hospital (1)
2086 - Frenchs Forest - GenesisCare Frenchs Forest (1)
2153 - Bella Vista - GenesisCare Norwest (1)
2220 - Hurstville - GenesisCare Hurstville (1)
Cancer Type
Cancer
Solid tumour
Thoracic cancer
Urogenital cancer
Lung cancer
Non-small cell lung cancer
Respiratory tract cancer
Urothelial carcinoma
Castrate-resistant prostate cancer
Male genital cancers
Prostate adenocarcinoma
Prostate cancer
Gastric adenocarcinoma
Gastric cancer
Gastric carcinoma
Gastroesophageal cancer
Gastroesophageal junction adenocarcinoma
Gastrointestinal cancer
HER2-positive gastric cancer
Oesophageal cancer
Upper gastrointestinal cancer
Breast cancer
URLs for this search
API URL:
Copy
Bookmarkable URL:
Copy